These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8545868)

  • 1. Combined simultaneous kidney/bone marrow transplantation.
    Shapiro R; Rao AS; Fontes P; Zeevi A; Jordan M; Scantlebury VP; Vivas C; Gritsch HA; Corry RJ; Egidi F
    Transplantation; 1995 Dec; 60(12):1421-5. PubMed ID: 8545868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
    Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients.
    Ciancio G; Burke GW; Garcia-Morales R; Suzart K; Rosen A; Ricordi C; Kenyon NS; Mathew JM; Tzakis AG; Esquenazi V; Miller J
    Transplantation; 2002 Aug; 74(4):488-96. PubMed ID: 12352907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Zucker K; Cirocco R; Ciancio G; Burke G; Roth D; Temple D; Rosen A; Fuller L; Esquenazi V; Karatzas T; Ricordi C; Tzakis A; Miller J
    J Clin Invest; 1997 Mar; 99(5):1118-29. PubMed ID: 9062371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow.
    Khanna A; Steptoe RJ; Antonysamy MA; Li W; Thomson AW
    Transplantation; 1998 Feb; 65(4):479-85. PubMed ID: 9500620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
    Chen B; Xu H; Corbin DR; Ildstad ST
    Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation.
    Fontes P; Rao AS; Demetris AJ; Zeevi A; Trucco M; Carroll P; Rybka W; Rudert WA; Ricordi C; Dodson F
    Lancet; 1994 Jul; 344(8916):151-5. PubMed ID: 7912764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-year clinical effect of donor bone marrow infusions in renal transplant patients.
    Ciancio G; Miller J; Garcia-Morales RO; Carreno M; Burke GW; Roth D; Kupin W; Tzakis AG; Ricordi C; Rosen A; Fuller L; Esquenazi V
    Transplantation; 2001 Apr; 71(7):827-35. PubMed ID: 11349712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients.
    Corry RJ; Chakrabarti PK; Shapiro R; Rao AS; Dvorchik I; Jordan ML; Scantlebury VP; Vivas CA; Fung JJ; Starzl TE
    Ann Surg; 1999 Sep; 230(3):372-9; discussion 379-81. PubMed ID: 10493484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.
    Oura T; Ko DS; Boskovic S; O'Neil JJ; Chipashvili V; Koulmanda M; Hotta K; Kawai K; Nadazdin O; Smith RN; Cosimi AB; Kawai T
    Cell Transplant; 2016; 25(7):1331-41. PubMed ID: 26337731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial.
    Hanto DW; Jendrisak MD; So SK; McCullough CS; Rush TM; Michalski SM; Phelan D; Mohanakumar T
    Transplantation; 1994 Feb; 57(3):377-84. PubMed ID: 8108873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of donor-specific bone marrow cell infusion on chimerism and acute rejection in kidney transplantation].
    Fu YW; Wang WG; Zhou HL; Zhang WL; Yang SJ; Wang JG
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1983-5. PubMed ID: 15730811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance.
    Kawai T; Poncelet A; Sachs DH; Mauiyyedi S; Boskovic S; Wee SL; Ko DS; Bartholomew A; Kimikawa M; Hong HZ; Abrahamian G; Colvin RB; Cosimi AB
    Transplantation; 1999 Dec; 68(11):1767-75. PubMed ID: 10609955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil in pancreas transplantation.
    Gruessner RW; Sutherland DE; Drangstveit MB; Wrenshall L; Humar A; Gruessner AC
    Transplantation; 1998 Aug; 66(3):318-23. PubMed ID: 9721799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.
    Li H; Colson YL; Ildstad ST
    Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-derived peripheral mononuclear cell DNA is associated with stable kidney allograft function: a randomized controlled trial.
    Solgi G; Mytilineos J; Gadi V; Paul B; Pourmand G; Mehrsai A; Nikbin B; Amirzargar AA
    Chimerism; 2011; 2(4):102-10. PubMed ID: 22509426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
    Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
    Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
    Sarwal MM; Cecka JM; Millan MT; Salvatierra O
    Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.